Dentists in Castleton, VT Accepting Medicare
2 Dentists found. Showing 1 - 2
 Dr. David Don Hassebroek, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: Rt. 30 Castleton Four Corners, Castleton, VT 05735 Phone: 802-468-5478 Fax: 802-468-3261 |
Dr. James Evans Wright, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1939 Route 4a, Castleton, VT 05735 Phone: 802-468-5626 Fax: 802-468-5628 |
News Archive
Inflammatory bowel disease linked to nerve damage and other neurological problems
People with inflammatory bowel disease may also be at risk for developing nerve damage and other neurological problems, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 , May 5, 2007.
HIV infection rates reaching epidemic proportion in Russia's vulnerable groups
HIV infection rates in vulnerable groups in Moscow could be between 30–120 times higher than those found in the general Russian Federation population, concludes a Research Letter.
Specific bacterial community in female genital tract induces inflammation, increases HIV risk
A team led by researchers from Massachusetts General Hospital and the Ragon Institute of MGH, MIT and Harvard has found that the most common bacterial community in the genital tract among healthy South Africa women not only is significantly different from that of women in developed countries but also leads to elevated levels of inflammatory proteins.
ACADIA Pharmaceuticals initiates pimavanserin Phase II trial in ADP patients
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has initiated a Phase II feasibility trial designed to examine the efficacy and safety of pimavanserin as a treatment for patients with Alzheimer's disease psychosis.
ICON receives FDA warning letter
ICON plc,, today announced it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006.
› Verified 4 days ago